StonvexLoading…
StonvexStonvexStonvexCore line items from CURI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $71.66M | $51.13M | $56.89M | $78.04M |
Operating Income | $-7.30M | $-13.33M | $-44.47M | $-55.28M |
Net Income | $-6.43M | $-12.94M | $-48.90M | $-50.92M |
EPS (Diluted) | $-0.11 | $-0.24 | $-0.92 | $-0.96 |
Total Assets | $75.73M | $86.18M | $101.02M | $154.11M |
Total Liabilities | $34.24M | $28.33M | $28.38M | $36.49M |
Cash & Equivalents | $18.32M | $7.83M | $37.72M | $40.01M |
Free Cash Flow OCF − CapEx | $12.96M | $8.15M | $-16.18M | $-39.65M |
Shares Outstanding | 58.73M | 56.60M | 53.29M | 52.85M |